Author of Vaccine-Autism Scare Planned to Cash In on Findings
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
Andrew Wakefield, who wrote the now-discredited 1998 study claiming a link between autism and a commonly administered vaccine, quietly planned businesses in Britain meant to capitalize on his findings, according to a new article.
The article was published today (Jan. 11) in the British Medical Journal as one of a series by British journalist Brian Deer. Deer's first article, which was peer-reviewed by the BMJ and published last week, exposed Wakefield's original study as an intentional fraud .
The new article revealed that the Royal Free Medical School in London supported Wakefield as he sought to profit from the study. Wakefield met with managers at the medical school to discuss business opportunities, even as the first child Wakefield investigated in the study was still in the hospital.
And just days after the original study was published, Wakefield brought business associates to the medical school to discuss potential partnerships, the article said.
One of the planned businesses, named after Wakefield's wife, would develop a vaccine to replace the measles, mumps and rubella (MMR) vaccine, which Wakefield alleged was causing autism . The company also planned to sell diagnostic testing kits for autism.
Financial forecasts showed that Wakefield and his business partners could have made $43 million a year from the autism diagnostic kits alone, according to the article.
A 35-page private prospectus obtained by Deer showed that Wakefield hoped to raise nearly $1.1 million from investors. By the company's third year in operation, Wakefield expected to make up to $43.46 million as his diagnostic testing kits and therapeutic regimens became more popular , the article said.
Get the world’s most fascinating discoveries delivered straight to your inbox.
Deer also discovered that Wakefield was given the opportunity to replicate his study of 12 children with a larger sample population of 150 patients, but he refused to try.
Pass it on: Andrew Wakefield, author of the debunked 1998 study claiming a link between autism and a vaccine, had planned businesses to capitalize off his findings.
- Vaccines and Autism Time line: How the Truth Unfolded
- Beyond Vaccines: 5 Things That Might Really Cause Autism
- Autism: Symptoms, Diagnosis and Treatments
Follow MyHealthNewsDaily staff writer Amanda Chan on Twitter @AmandaLChan.

